| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/18/2023 | X4 Pharmaceuticals, Inc | XFOR | Purchase | Common Stock | 25k | $1.20 | $29.9k | | 08/18/2023 |
| 05/23/2023 | Invivyd, Inc. | | Grant | Stock Option (Right to Buy) | 50k | $1.70 | $85k | | 05/23/2023 |
| 11/16/2022 | LogicBio Therapeutics, Inc. | LOGC | Disposition | Common Stock | 3.1k | $0.00 | $0 | | 11/16/2022 |
| 11/16/2022 | LogicBio Therapeutics, Inc. | LOGC | Disposition | Stock Option (right to buy) | 12.5k | $0.38 | $4.8k | | 11/16/2022 |
| 06/22/2022 | Invivyd, Inc. | | Grant | Stock Option (Right to Buy) | 75k | $3.09 | $231.8k | | 06/22/2022 |
| 06/17/2022 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 12.5k | $0.38 | $4.8k | | 06/17/2022 |
| 06/06/2022 | X4 Pharmaceuticals, Inc | XFOR | Grant | Common Stock | 6.7k | $0.00 | $0 | | 06/06/2022 |
| 08/05/2021 | Invivyd, Inc. | | Grant | Stock Option (Right to Buy) | 71.2k | $17.00 | $1.2M | | 08/05/2021 |
| 06/11/2021 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 12.5k | $4.59 | $57.4k | | 06/11/2021 |
| 06/02/2021 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 6k | $9.50 | $57k | | 06/02/2021 |
| 02/26/2021 | EXACT SCIENCES CORP | EXAS | Sale | Common Stock | 19k | $130.11 | $2.5M | | 02/26/2021 |
| 02/26/2021 | EXACT SCIENCES CORP | EXAS | Exercise | Stock Option (right to buy) | 10.1k | $26.98 | $272.7k | | 02/26/2021 |
| 01/01/2021 | LogicBio Therapeutics, Inc. | LOGC | Exercise | Restricted Stock Units | 3.1k | $0.00 | $0 | | 01/01/2021 |
| 07/23/2020 | EXACT SCIENCES CORP | EXAS | Grant | | 2.6k | $0.00 | $0 | | 07/23/2020 |
| 06/19/2020 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 10k | $7.96 | $79.6k | | 06/19/2020 |
| 06/19/2020 | LogicBio Therapeutics, Inc. | LOGC | Grant | Restricted Stock Units | 3.1k | $0.00 | $0 | | 06/19/2020 |
| 06/10/2020 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 3.4k | $8.69 | $29.8k | | 06/10/2020 |
| 12/19/2019 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 10.9k | $12.65 | $137.5k | | 12/19/2019 |
| 07/25/2019 | EXACT SCIENCES CORP | EXAS | Grant | | 2.8k | $0.00 | $0 | | 07/25/2019 |
| 03/13/2019 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 70.3k | $10.44 | $734.2k | | 03/13/2019 |
| 03/13/2019 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 6.9k | $18.66 | $127.9k | | 03/13/2019 |
| 03/13/2019 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 70.3k | $10.44 | $734.2k | | 03/13/2019 |
| 02/28/2019 | EXACT SCIENCES CORP | EXAS | Sale | Common Stock | 500 | $96.00 | $48k | | 02/28/2019 |
| 10/18/2018 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 24.1k | $10.00 | $241k | | 10/18/2018 |
| 08/28/2018 | EXACT SCIENCES CORP | EXAS | Sale | Common Stock | 2.5k | $74.85 | $184.7k | | 08/28/2018 |
| 07/26/2018 | EXACT SCIENCES CORP | EXAS | Grant | | 606 | $0.00 | $0 | | 07/26/2018 |
| 07/26/2018 | EXACT SCIENCES CORP | EXAS | Grant | | 3.2k | $0.00 | $0 | | 07/26/2018 |
| 06/22/2018 | OncoMed Pharmaceuticals Inc | OMED | Grant | Stock Option (Right to Buy) | 15k | $2.55 | $38.2k | | 06/22/2018 |
| 06/14/2018 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 12.5k | $11.14 | $139.2k | | 06/14/2018 |
| 05/10/2018 | EXACT SCIENCES CORP | EXAS | Sale | Common Stock | 7.4k | $51.53 | $381.4k | | 05/10/2018 |
| 06/15/2017 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 12.5k | $14.37 | $179.6k | | 06/15/2017 |
| 06/16/2016 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 12.5k | $8.56 | $107k | | 06/16/2016 |
| 06/19/2015 | OncoMed Pharmaceuticals Inc | OMED | Grant | Stock Option (Right to Buy) | 15k | $25.45 | $381.8k | | 06/19/2015 |
| 06/10/2015 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to Buy) | 5k | $7.86 | $39.3k | | 06/10/2015 |
| 02/09/2015 | EXACT SCIENCES CORP | EXAS | Grant | Stock Option (right to buy) | 12.6k | $26.98 | $340.2k | | 02/09/2015 |
|